Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Evans

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Oncogene|March 26, 2014
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft modelH G Nguyen, J C Yang, H-J Kung, et al.
Cell Death & Disease|September 5, 2014
Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitorW Guo, R Liu, G Bhardwaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2017
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweetA J Armstrong, E S Antonarakis, M-E Taplin, et al.
BMJ Military Health|July 25, 2022
Development and operation of the defence COVID-19 lab as a SARS-CoV-2 diagnostic screening capability for UK military personnelSimon A Weller, S R Armstrong, S Bailey, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Oncogene|March 26, 2014
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft modelH G Nguyen, J C Yang, H-J Kung, et al.
Cell Death & Disease|September 5, 2014
Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitorW Guo, R Liu, G Bhardwaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2017
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweetA J Armstrong, E S Antonarakis, M-E Taplin, et al.
BMJ Military Health|July 25, 2022
Development and operation of the defence COVID-19 lab as a SARS-CoV-2 diagnostic screening capability for UK military personnelSimon A Weller, S R Armstrong, S Bailey, et al.
Pageof 4